ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 675,62
-0,26%
Dow Jones
39 375,87
0,17%
DAX
18 475,45
0,12%
Brent Oil
86,775
0,00%
Bitcoin
57 468,13
-1,43%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Osmotica Pharmaceuticals PLC (OSMT)

  7. Osmotica Pharmaceuticals PLC (OSMT) Actualités

OSMT

Osmotica Pharmaceuticals (OSMT)

Osmotica Pharmaceuticals PLC
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OSMT
DateHeureSourceTitreSymboleSociété
16/06/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/05/202322h24Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322h26Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322h17Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
24/04/202322h13Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/03/202322h26Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
27/01/202322h11Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
26/01/202323h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/08/202222h07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/202221h53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/202223h21Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/04/202223h05Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
30/03/202222h52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202217h38GlobeNewswire Inc.UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
19/01/202212h50GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales GuidanceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
18/01/202212h50GlobeNewswire Inc.RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/01/202214h55GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022NASDAQ:OSMTOsmotica Pharmaceuticals PLC
23/12/202112h15TipRanksH.C. Wainwright Thinks Osmotica Pharmaceuticals’ Stock is Going to RecoverNASDAQ:OSMTOsmotica Pharmaceuticals PLC
20/12/202122h05GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
16/11/202123h13Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202122h05GlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Third Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
15/11/202112h50GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Jefferies London Virtual Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
12/11/202101h30GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Third Quarter 2021 Business and Financial Update on November 15, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/10/202122h28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
13/10/202122h45GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/10/202123h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202115h04GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
07/10/202106h31GlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/10/202122h26GlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
22/09/202123h00GlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:OSMT

Dernières Valeurs Consultées

BIT
WTI1L
Sg Etc Wti Oil Future
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés